Literature DB >> 19091536

Improving mucociliary clearance in chronic obstructive pulmonary disease.

Angshu Bhowmik1, Kamaljeet Chahal, Gillian Austin, Indranil Chakravorty.   

Abstract

Patients with COPD usually experience mucus hypersecretion as a result of airway inflammation and response to noxious stimuli. These in turn lead to worsening airway resistance, impaired airflow, increased work of breathing, dyspnoea and exercise intolerance. Mucus hypersecretion may also lead to increased exacerbations and poor health related quality of life (HRQL). Institution based pulmonary rehabilitation programs incorporating airway clearance techniques have been shown to improve HRQL, reduce dyspnoea and improve exercise tolerance but are often difficult to provide due to restricted accessibility and resource implications. This review examines the current evidence base and best clinical practice in the area of airway clearance. Mechanical devices such as the flutter valves, positive end expiratory pressure and high frequency chest wall oscillation (HFCWO) may be able to provide the benefits of improved airway clearance in the patient's home potentially with reduced demands on healthcare resources.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091536     DOI: 10.1016/j.rmed.2008.10.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

1.  [Guidelines for outpatient pulmonary rehabilitation in Austria].

Authors:  Karin Vonbank; Ralf Harun Zwick; Michaela Strauss; Alfred Lichtenschopf; Christoph Puelacher; Agnes Budnowski; Gabriele Possert; Martin Trinker
Journal:  Wien Klin Wochenschr       Date:  2015-04-03       Impact factor: 1.704

Review 2.  Pulmonary epithelial barrier function: some new players and mechanisms.

Authors:  Kieran Brune; James Frank; Andreas Schwingshackl; James Finigan; Venkataramana K Sidhaye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-30       Impact factor: 5.464

3.  Large-conductance Ca2+ -activated K+ channel activation by apical P2Y receptor agonists requires hydrocortisone in differentiated airway epithelium.

Authors:  Nathan A Zaidman; Angela Panoskaltsis-Mortari; Scott M O'Grady
Journal:  J Physiol       Date:  2017-06-11       Impact factor: 5.182

Review 4.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

Review 5.  Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency.

Authors:  C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  Benefit of educational feedback for the use of positive expiratory pressure device.

Authors:  Gregory Reychler; Manon Jacquemart; William Poncin; Anne-Sophie Aubriot; Giuseppe Liistro
Journal:  Braz J Phys Ther       Date:  2015-09-01       Impact factor: 3.377

7.  Clinical management practices adopted by physiotherapists in India for chronic obstructive pulmonary disease: A national survey.

Authors:  Aripta Jingar; Gopala Krishna Alaparthi; K Vaishali; Shyam Krishnan; B Unnikrishnan
Journal:  Lung India       Date:  2013-04

8.  A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion.

Authors:  Indranil Chakravorty; Kamaljit Chahal; Gillian Austin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-12-14

9.  Cold bubble humidification of low-flow oxygen does not prevent acute changes in inflammation and oxidative stress at nasal mucosa.

Authors:  Lauriana Alves Santana; Suellen Karoline Moreira Bezerra; Beatriz Mangueira Saraiva-Romanholo; Wellington Pereira Yamaguti; Iolanda de Fátima Lopes Calvo Tibério; Tabata Maruyama Dos Santos; Renato Fraga Righetti
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

Review 10.  Barrier function of airway tract epithelium.

Authors:  Shyamala Ganesan; Adam T Comstock; Uma S Sajjan
Journal:  Tissue Barriers       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.